Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology

10.1002/eji.202149488

Saved in:
Bibliographic Details
Main Authors: Weigand, K, Peschel, G, Grimm, J, Luu, K, Schacherer, D, Wiest, R, Müller, M, Schwarz, H, Buechler, C
Other Authors: PHYSIOLOGY
Format: Article
Published: Wiley 2023
Subjects:
TNF
Online Access:https://scholarbank.nus.edu.sg/handle/10635/239107
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-239107
record_format dspace
spelling sg-nus-scholar.10635-2391072023-08-29T21:36:38Z Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology Weigand, K Peschel, G Grimm, J Luu, K Schacherer, D Wiest, R Müller, M Schwarz, H Buechler, C PHYSIOLOGY Direct-acting antivirals Foxp3 MELD score TNF liver cirrhosis Antiviral Agents Biomarkers Hepacivirus Hepatitis C Hepatitis C, Chronic Humans Liver Cirrhosis 10.1002/eji.202149488 European Journal of Immunology 52 4 633-645 2023-05-02T07:53:09Z 2023-05-02T07:53:09Z 2022-04-01 2023-05-02T03:41:52Z Article Weigand, K, Peschel, G, Grimm, J, Luu, K, Schacherer, D, Wiest, R, Müller, M, Schwarz, H, Buechler, C (2022-04-01). Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology. European Journal of Immunology 52 (4) : 633-645. ScholarBank@NUS Repository. https://doi.org/10.1002/eji.202149488 0014-2980 1521-4141 https://scholarbank.nus.edu.sg/handle/10635/239107 Wiley Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Direct-acting antivirals
Foxp3
MELD score
TNF
liver cirrhosis
Antiviral Agents
Biomarkers
Hepacivirus
Hepatitis C
Hepatitis C, Chronic
Humans
Liver Cirrhosis
spellingShingle Direct-acting antivirals
Foxp3
MELD score
TNF
liver cirrhosis
Antiviral Agents
Biomarkers
Hepacivirus
Hepatitis C
Hepatitis C, Chronic
Humans
Liver Cirrhosis
Weigand, K
Peschel, G
Grimm, J
Luu, K
Schacherer, D
Wiest, R
Müller, M
Schwarz, H
Buechler, C
Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology
description 10.1002/eji.202149488
author2 PHYSIOLOGY
author_facet PHYSIOLOGY
Weigand, K
Peschel, G
Grimm, J
Luu, K
Schacherer, D
Wiest, R
Müller, M
Schwarz, H
Buechler, C
format Article
author Weigand, K
Peschel, G
Grimm, J
Luu, K
Schacherer, D
Wiest, R
Müller, M
Schwarz, H
Buechler, C
author_sort Weigand, K
title Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology
title_short Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology
title_full Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology
title_fullStr Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology
title_full_unstemmed Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology
title_sort soluble cd137 is a novel serum marker of liver cirrhosis in patients with hepatitis c and alcohol-associated disease etiology
publisher Wiley
publishDate 2023
url https://scholarbank.nus.edu.sg/handle/10635/239107
_version_ 1779155613534650368